The role of human epididymis protein 4 as a biomarker in gynecologic malignancies.
Plotti F, Scaletta G, Terranova C, Montera R, De Cicco Nardone C, Luvero D, Rossini G, Gatti A, Schirò T, Moncelli M, Guzzo F, Angioli R.
Minerva Ginecol. 2019 Feb;71(1):36-43. doi: 10.23736/S0026-4784.18.04328-9. Epub 2018 Oct 11.
PMID:30318876
Adolescent Hydrocele Carrying a Surprise: A Case of Papillary Cystadenoma of the Epididymis.
Soria Gondek A, Julià Masip V, Jou Muñoz C, Salvador Hernández H, Rovira Zurriaga C, Tarrado Castellarnau X.
Urology. 2018 Feb;112:172-175. doi: 10.1016/j.urology.2017.10.040. Epub 2017 Nov 15.
PMID:29154985
Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
Kotowicz B, Fuksiewicz M, Sobiczewski P, Spiewankiewicz B, Jonska-Gmyrek J, Skrzypczak M, Kowalska M.
Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass.
Yu XP, Liu Y, Jiao JW, Yang HJ, Wang RJ, Zhang S.
Med Sci Monit. 2020 Aug 17;26:e924497. doi: 10.12659/MSM.924497.
PMID:32801292
Appendageal tumors and tumor-like lesions of the testis and paratestis: a 32-year experience at a single institution.
Al-Obaidy KI, Alruwaii FI, Ulbright TM, Idrees MT.
Hum Pathol. 2020 Sep;103:25-33. doi: 10.1016/j.humpath.2020.06.006. Epub 2020 Jun 30.